Feb 2023: Enhertu (trastuzumab deruxtecan) from AstraZeneca and Daiichi Sankyo has been approved as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received o..
Feb 2023: Hamsa Nandini, who was diagnosed with Grade III Invasive Carcinoma (Breast Cancer) in 2021, has updated her Instagram followers on her health status. The actress, who has appeared in Telugu films such as Mirchi and Lege..
Breast & ovarian cancerIf you are a breast and ovarian cancer patient, you happen to find that you are a cancer of the BRCA1 / 2 mutation after passing the genetic test, and your life is saved. According to the Global Oncolog..
Breast cancer situation Approximately every 10-12% of breast cancer patients in the world are in India, and nearly two-thirds of patients are diagnosed with advanced cancer at the time of diagnosis. Experts analyzed that there s..
Breast cancer problemBreast cancer is a common female malignant tumor that seriously threatens the physical and mental health of women, so it is also known as the "red killer". Statistics show that breast cancer causes 458,000 de..
Breast cancer & chemotherapyAmong the many cancers, breast cancer is probably the most difficult to decide whether to undergo chemotherapy after surgery. Similar to other cancers, the factors that determine breast cancer chem..
Breast cancer With the advancement of breast cancer diagnosis and treatment, the survival time of breast cancer patients has prolonged significantly, but the incidence of breast cancer brain metastases (BCBM) has gradually increa..
New studies have found that taking supplements like antioxidants may carry significant risk during breast cancer chemotherapy. A small study found out that patient taking supplements during breast cancer chemotherapy have higher c..
There is a new emerging treatment option for metastatic HER2-positive breast cancer. Following very encouraging & positive results from two clinical trials these options have emerged. The trials tested the drugs tucatinib and ..
Treatment of breast cancer has progressed very rapidly in last few years and there have been new developments in the treatment of breast cancer. Research director Dr Juha Klefstorm at University of Helsinki who is working for a..